2004Unpublished venueRequires access

Hu-CD8/CD38/CD3/HLA-DR 4 Color FCM Reagent: sc-2910

Santa Cruz

Open publisher page 0 citations

Abstract

BACKGROUND Human CD8/CD38/CD3/HLA-DR: sc-2910 is a direct immunofluorescence reagent formatted to identify the percentage of activated T-suppressor/cytotoxic lymphocytes (1) in erythrocytelysed whole blood, based on cell-surface antigen expression. CD8 identifies suppressor/cytotoxic T lymphocytes and binds class I MHC molecules, which enhances the activation of resting T lymphocytes (2). CD38 is expressed during the early and final stages of T and B cell differentiation, but not during the intermediate stage (3). CD3 identifies T lymphocytes and noncovalently associates with either α/β or γ/δ TCR (4). HLA-DR is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes and human progenitor cells (5). Reductions in the percentage and absolute number of CD4+ cells, as well as abnormally high levels of activated peripheral T cells and an increased proportion of CD8+ cells coexpressing CD57 (involved in NK activity) have been reported in HIV infection and associated with disease progression (1).

About this research paper

What this paper is about

BACKGROUND Human CD8/CD38/CD3/HLA-DR: sc-2910 is a direct immunofluorescence reagent formatted to identify the percentage of activated T-suppressor/cytotoxic lymphocytes (1) in erythrocytelysed whole blood, based on cell-surface antigen expression. CD8 identifies suppressor/cytotoxic T lymphocytes and binds class I MHC molecules, which enhances the activation of resting T lymphocytes (2). CD38 is expressed during the early and final stages of T and B cell differentiation, but not during the intermediate stage (3). CD3 identifies T lymphocytes and noncovalently associates with either α/β or γ/δ TCR (4). HLA-DR is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes and human progenitor cells (5). Reductions in the percentage and absolute number of CD4+ cells, as well as abnormally high levels of activated peripheral T cells and an increased proportion of CD8+ cells coexpressing CD57 (involved in NK activity) have been reported in HIV infection and associated with disease progression (1).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

BACKGROUND Human CD8/CD38/CD3/HLA-DR: sc-2910 is a direct immunofluorescence reagent formatted to identify the percentage of activated T-suppressor/cytotoxic lymphocytes (1) in erythrocytelysed whole blood, based on cell-surface antigen expression. CD8 identifies suppressor/cytotoxic T lymphocytes and binds class I MHC molecules, which enhances the activation of resting T lymphocytes (2). CD38 is expressed during the early and final stages of T and B cell differentiation, but not during the intermediate stage (3). CD3 identifies T lymphocytes and noncovalently associates with either α/β or γ/δ TCR (4). HLA-DR is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes and human progenitor cells (5). Reductions in the percentage and absolute number of CD4+ cells, as well as abnormally high levels of activated peripheral T cells and an increased proportion of CD8+ cells coexpressing CD57 (involved in NK activity) have been reported in HIV infection and associated with disease progression (1).

Key concepts: Cytotoxic T cell, CD8, CD38, CD3, Molecular biology, Biology, Human leukocyte antigen, T lymphocyte

Related papers

Back to paper searchBrowse research topicsOriginal source
Hu-CD8/CD38/CD3/HLA-DR 4 Color FCM Reagent: sc-2910 — Research Paper | ScholarLens